Yesterday it was reported that the Chairman & CEO of NantKwest (NK), Shiong Patrick Soon, exercised options to buy 19,440,750 NK shares at $2.00 a share, for a total transaction value of $4.05M. The options were close to expired and Shiong Patrick Soon retained stocks.
This recent transaction increases Shiong Patrick Soon’s holding in the company by 41.55% to a total of $88.75 million.
See today’s analyst top recommended stocks >>
Currently, NantKwest has an average volume of 342.2K.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
NantKwest, Inc. engages in the development of immunotherapies with a focus on harnessing the power of the innate immune system. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The firm operates through the following geographical segments: United States; Europe; and Other Non-U.S. The company was founded by Gary N.
